Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Retained Earnings (2023 - 2025)

Lamy (LMMY) has disclosed Retained Earnings for 3 consecutive years, with -$288623.0 as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 8349.15% to -$288623.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$288623.0 through Nov 2025, down 8349.15% year-over-year, with the annual reading at -$31770.0 for FY2025, 61.8% up from the prior year.
  • Retained Earnings hit -$288623.0 in Q4 2025 for Lamy, down from -$63584.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$3416.0 in Q4 2024 to a low of -$288623.0 in Q4 2025.
  • Historically, Retained Earnings has averaged -$74530.6 across 3 years, with a median of -$66551.5 in 2023.
  • Biggest five-year swings in Retained Earnings: skyrocketed 95.33% in 2024 and later plummeted 8349.15% in 2025.
  • Year by year, Retained Earnings stood at -$73092.0 in 2023, then surged by 95.33% to -$3416.0 in 2024, then tumbled by 8349.15% to -$288623.0 in 2025.
  • Business Quant data shows Retained Earnings for LMMY at -$288623.0 in Q4 2025, -$63584.0 in Q3 2025, and -$31770.0 in Q2 2025.